The San Diego Supercomputer Center (SDSC) is powering a latest artificial intelligence (AI) model designed to improve the accuracy and speed of prostate cancer care, according to announcements from UC San Diego Today and HPCwire.
The AI model, developed by researchers at UC San Diego, aims to enhance the process of radiotherapy planning for prostate cancer patients. Details regarding the specific algorithms or datasets used in the model’s development were not immediately available, but the project leverages the computational resources of the SDSC to process complex medical imaging data and treatment plans.
The initiative comes as artificial intelligence is increasingly explored for its potential to transform cancer treatment. A separate project at UC San Diego, also highlighted by UC San Diego Today, focuses on an AI tool to improve cervical cancer treatment planning. This parallel effort underscores a broader trend toward AI-assisted oncology.
The application of AI in radiotherapy, particularly for prostate cancer, is gaining traction internationally. Researchers writing in the journal Frontiers have described the potential for AI-assisted radiotherapy to be a “transformational opportunity” in Morocco, suggesting a global interest in adopting these technologies to improve cancer care access and outcomes.
The SDSC’s involvement provides the necessary high-performance computing infrastructure to support the AI model’s intensive data processing requirements. HPCwire reported that the SDSC is providing the computational power needed to accelerate the development and deployment of this technology.
Further details regarding clinical trials or planned implementation of the AI model were not disclosed in the available reports. The UC San Diego and SDSC have not yet issued statements regarding timelines for wider adoption or potential partnerships with healthcare providers.
